Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis.
<h4>Background</h4>Cancer-related fatigue (CRF) is a common symptom affecting patients with cancer. There are an increasing number of trials examining potential treatments for CRF. Methylphenidate represents one of the most researched drugs and an up-to-date assessment of the evidence fo...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0084391 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849411921909907456 |
|---|---|
| author | Shun Gong Ping Sheng Hai Jin Hua He Enbo Qi Wen Chen Yan Dong Lijun Hou |
| author_facet | Shun Gong Ping Sheng Hai Jin Hua He Enbo Qi Wen Chen Yan Dong Lijun Hou |
| author_sort | Shun Gong |
| collection | DOAJ |
| description | <h4>Background</h4>Cancer-related fatigue (CRF) is a common symptom affecting patients with cancer. There are an increasing number of trials examining potential treatments for CRF. Methylphenidate represents one of the most researched drugs and an up-to-date assessment of the evidence for its use is needed. Trials of methylphenidate for CRF provided inconsistent results. This meta-analysis was aimed at assessing the effect and safety of methylphenidate on CRF.<h4>Methods</h4>We comprehensively searched the Pubmed, EMBASE, PSYCHInfo and the Cochrane databases in order to identify published studies on the effect of methylphenidate on CRF. Primary outcomes included fatigue. Secondary outcomes included depression, cognition and adverse effects.<h4>Findings</h4>A meta-analysis was conducted on five randomized controlled trials and 498 patients were enrolled. Despite a large placebo effect observed in the studies included, pooled data suggested therapeutic effect of methylphenidate on CRF. Subgroup Analyses showed that the efficacy of methylphenidate on CRF is getting better with prolonging treatment duration, with a MD of -3.70 (95% CI -7.03- -0.37, p = 0.03) for long-time group and a MD of -2.49 (95% CI -6.01-1.03, p = 0.17) for short-time group. In general, there was no impact of methylphenidate on depression and cognition associated with CRF. Adverse events were similar between methylphenidate and placebo groups except that more patients reported vertigo, anxiety, anorexia and nausea in methylphenidate group compared to placebo group.<h4>Conclusion</h4>Existing trials of methylphenidate on CRF provided limited evidence for the use of methylphenidate to treat CRF. The absolute numbers still remain small, and further confirmation is needed before firm recommendations on their usage and safety can be made in the treatment of CRF. |
| format | Article |
| id | doaj-art-cefe065f1ca247b3af86ed7b298c6421 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-cefe065f1ca247b3af86ed7b298c64212025-08-20T03:34:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8439110.1371/journal.pone.0084391Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis.Shun GongPing ShengHai JinHua HeEnbo QiWen ChenYan DongLijun Hou<h4>Background</h4>Cancer-related fatigue (CRF) is a common symptom affecting patients with cancer. There are an increasing number of trials examining potential treatments for CRF. Methylphenidate represents one of the most researched drugs and an up-to-date assessment of the evidence for its use is needed. Trials of methylphenidate for CRF provided inconsistent results. This meta-analysis was aimed at assessing the effect and safety of methylphenidate on CRF.<h4>Methods</h4>We comprehensively searched the Pubmed, EMBASE, PSYCHInfo and the Cochrane databases in order to identify published studies on the effect of methylphenidate on CRF. Primary outcomes included fatigue. Secondary outcomes included depression, cognition and adverse effects.<h4>Findings</h4>A meta-analysis was conducted on five randomized controlled trials and 498 patients were enrolled. Despite a large placebo effect observed in the studies included, pooled data suggested therapeutic effect of methylphenidate on CRF. Subgroup Analyses showed that the efficacy of methylphenidate on CRF is getting better with prolonging treatment duration, with a MD of -3.70 (95% CI -7.03- -0.37, p = 0.03) for long-time group and a MD of -2.49 (95% CI -6.01-1.03, p = 0.17) for short-time group. In general, there was no impact of methylphenidate on depression and cognition associated with CRF. Adverse events were similar between methylphenidate and placebo groups except that more patients reported vertigo, anxiety, anorexia and nausea in methylphenidate group compared to placebo group.<h4>Conclusion</h4>Existing trials of methylphenidate on CRF provided limited evidence for the use of methylphenidate to treat CRF. The absolute numbers still remain small, and further confirmation is needed before firm recommendations on their usage and safety can be made in the treatment of CRF.https://doi.org/10.1371/journal.pone.0084391 |
| spellingShingle | Shun Gong Ping Sheng Hai Jin Hua He Enbo Qi Wen Chen Yan Dong Lijun Hou Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS ONE |
| title | Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. |
| title_full | Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. |
| title_fullStr | Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. |
| title_full_unstemmed | Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. |
| title_short | Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. |
| title_sort | effect of methylphenidate in patients with cancer related fatigue a systematic review and meta analysis |
| url | https://doi.org/10.1371/journal.pone.0084391 |
| work_keys_str_mv | AT shungong effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis AT pingsheng effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis AT haijin effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis AT huahe effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis AT enboqi effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis AT wenchen effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis AT yandong effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis AT lijunhou effectofmethylphenidateinpatientswithcancerrelatedfatigueasystematicreviewandmetaanalysis |